236 related articles for article (PubMed ID: 32086052)
21. Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile.
Haroun M; Fesatidou M; Petrou A; Tratrat C; Zagaliotis P; Gavalas A; Venugopala KN; Kochkar H; Emeka PM; Younis NS; Elmaghraby DA; Almostafa MM; Chohan MS; Vizirianakis IS; Papadimitriou-Tsantarliotou A; Geronikaki A
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110650
[TBL] [Abstract][Full Text] [Related]
22. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA
Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
[TBL] [Abstract][Full Text] [Related]
23. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, biological evaluation, docking study and ulcerogenicity profiling of some novel quinoline-2-carboxamides as dual COXs/LOX inhibitors endowed with anti-inflammatory activity.
Abdelrahman MH; Youssif BGM; Abdelgawad MA; Abdelazeem AH; Ibrahim HM; Moustafa AEGA; Treamblu L; Bukhari SNA
Eur J Med Chem; 2017 Feb; 127():972-985. PubMed ID: 27837994
[TBL] [Abstract][Full Text] [Related]
25. Aspirin analogues as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, nitric oxide release, molecular modeling, and biological evaluation as anti-inflammatory agents.
Kaur J; Bhardwaj A; Huang Z; Knaus EE
ChemMedChem; 2012 Jan; 7(1):144-50. PubMed ID: 22095955
[TBL] [Abstract][Full Text] [Related]
26. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
Lamie PF; Ali WAM; Bazgier V; Rárová L
Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
[TBL] [Abstract][Full Text] [Related]
27. Towards safer anti-inflammatory therapy: synthesis of new thymol-pyrazole hybrids as dual COX-2/5-LOX inhibitors.
El-Miligy MMM; Al-Kubeisi AK; Bekhit MG; El-Zemity SR; Nassra RA; Hazzaa AA
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):294-308. PubMed ID: 36408833
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
30. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of new pyrazoloquinazoline derivatives as dual COX-2/5-LOX inhibitors.
Shaaban MA; Kamal AM; Faggal SI; Farag NA; Aborehab NM; Elsahar AE; Mohamed KO
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000027. PubMed ID: 32696514
[TBL] [Abstract][Full Text] [Related]
32. Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR.
Meshram MA; Bhise UO; Makhal PN; Kaki VR
Eur J Med Chem; 2021 Dec; 225():113804. PubMed ID: 34479036
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory Activity of Natural Geranylated Flavonoids: Cyclooxygenase and Lipoxygenase Inhibitory Properties and Proteomic Analysis.
Hanáková Z; Hošek J; Kutil Z; Temml V; Landa P; Vaněk T; Schuster D; Dall'Acqua S; Cvačka J; Polanský O; Šmejkal K
J Nat Prod; 2017 Apr; 80(4):999-1006. PubMed ID: 28322565
[TBL] [Abstract][Full Text] [Related]
34. Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation.
Kaur G; Silakari O
Bioorg Chem; 2018 Oct; 80():24-35. PubMed ID: 29864685
[TBL] [Abstract][Full Text] [Related]
35. Exploring new imines as anti-inflammatory COX and 5-LOX inhibitors with an improved pharmacokinetic profile.
Said MF; Moussa BA; Mahrouse MA; Marie SM; Mohamed NM
Future Med Chem; 2024 Feb; 16(4):311-334. PubMed ID: 38293746
[No Abstract] [Full Text] [Related]
36. Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies.
Theoduloz C; Alzate-Morales J; Jiménez-Aspee F; Isla MI; Alberto MR; Pertino MW; Schmeda-Hirschmann G
Chem Biol Drug Des; 2019 Mar; 93(3):290-299. PubMed ID: 30294891
[TBL] [Abstract][Full Text] [Related]
37. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies.
Rudrapal M; Eltayeb WA; Rakshit G; El-Arabey AA; Khan J; Aldosari SM; Alshehri B; Abdalla M
Sci Rep; 2023 May; 13(1):8656. PubMed ID: 37244921
[TBL] [Abstract][Full Text] [Related]
38. Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: Synthesis, biopharmacological evaluation and molecular modeling studies.
Elgohary MK; Abd El Hadi SR; Abo-Ashour MF; Abo-El Fetoh ME; Afify H; Abdel-Aziz HA; Abou-Seri SM
Bioorg Chem; 2023 Oct; 139():106724. PubMed ID: 37451146
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of novel hybrids of pyrazole and coumarin as dual inhibitors of COX-2 and 5-LOX.
Shen FQ; Wang ZC; Wu SY; Ren SZ; Man RJ; Wang BZ; Zhu HL
Bioorg Med Chem Lett; 2017 Aug; 27(16):3653-3660. PubMed ID: 28720504
[TBL] [Abstract][Full Text] [Related]
40. Novel 5,6-diphenyl-1,2,4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity.
Saraf P; Nath Tripathi P; Kumar Tripathi M; Tripathi A; Verma H; Kumar Waiker D; Singh R; Kumar Shrivastava S
Bioorg Chem; 2022 Dec; 129():106147. PubMed ID: 36126607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
